Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (281-290 of 351) with videos related to

Pageof 36
Sort By:
JAMA Dermatology|June 15, 2017
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked ProtoporphyriaManisha Balwani, Hetanshi Naik, Karl E Anderson, et al.
Molecular Medicine (Cambridge, Mass.)|February 1, 2013
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyriaManisha Balwani, Dana Doheny, David F Bishop, et al.
Virology Journal|April 26, 2005
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysisStephen J Polyak, Daniel G Sullivan, Michael A Austin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2008
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis CKaren L Lindsay, Chihiro Morishima, Elizabeth C Wright, et al.
Journal of Hepatology|September 24, 2022
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injuryNaga Chalasani, Yi-Ju Li, Andrew Dellinger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
The Journal of Infectious Diseases|March 7, 2006
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis CChihiro Morishima, Stephen J Polyak, Ranjit Ray, et al.
Pageof 36

Showing results (281-290 of 351) with videos related to

Sort By:
Pageof 36
JAMA Dermatology|June 15, 2017
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked ProtoporphyriaManisha Balwani, Hetanshi Naik, Karl E Anderson, et al.
Molecular Medicine (Cambridge, Mass.)|February 1, 2013
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyriaManisha Balwani, Dana Doheny, David F Bishop, et al.
Virology Journal|April 26, 2005
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysisStephen J Polyak, Daniel G Sullivan, Michael A Austin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2008
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis CKaren L Lindsay, Chihiro Morishima, Elizabeth C Wright, et al.
Journal of Hepatology|September 24, 2022
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injuryNaga Chalasani, Yi-Ju Li, Andrew Dellinger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
The Journal of Infectious Diseases|March 7, 2006
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis CChihiro Morishima, Stephen J Polyak, Ranjit Ray, et al.
Pageof 36